Type 1 diabetes (T1D) is a complex autoimmune disease in which immune cells react against insulin-producing beta cells within the pancreatic islets of Langerhans [1], [2], leaving affected individuals dependent upon exogenous insulin for life, and at high risk for developing serious cardiovascular and microvascular complications. Here, INS is linked to autoimmune disease.